神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

中国中晚期帕金森病运动症状治疗的循证医学指南

2021-09-15 中国医师协会神经内科医师分会帕金森病及运动障碍学组 中国神经免疫学和神经病学杂志

帕金森病神经变性疾病运动症状

帕金森病(Parkinson disease, PD)是一种常见的中枢神经系统变性疾病,随着疾病进展至中晚期后,PD并发症的出现使其治疗变得非常困难。

中文标题：

中国中晚期帕金森病运动症状治疗的循证医学指南

发布机构：

中国医师协会神经内科医师分会帕金森病及运动障碍学组

发布日期：

2021-09-15

简要介绍：

帕金森病(Parkinson disease, PD)是一种常见的中枢神经系统变性疾病,随着疾病进展至中晚期后,PD并发症的出现使其治疗变得非常困难。近年来国际上对于中晚期PD的治疗和管理有了更多新的循证医学证据。中华医学会神经病学分会帕金森病及运动障碍学组和中国医师协会神经内科医师分会帕金森病及运动障碍学组组织有关专家,在循证医学原则指导下,就国内针对中晚期PD运动症状的现有干预措施研究进行总结,经多次讨论形成此指南,并就中晚期PD运动症状不同治疗措施的证据等级、推荐强度、安全性给出推荐,以更好地指导我国中晚期PD治疗的临床实践。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国中晚期帕金森病运动症状治疗的循证医学指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2a0e91c0023a93ae, title=中国中晚期帕金森病运动症状治疗的循证医学指南, enTitle=, guiderFrom=中国神经免疫学和神经病学杂志, authorId=0, author=, summary=帕金森病(Parkinson disease, PD)是一种常见的中枢神经系统变性疾病,随着疾病进展至中晚期后,PD并发症的出现使其治疗变得非常困难。, cover=https://img.medsci.cn/202229/1644416468134_5579292.png, journalId=0, articlesId=null, associationId=2384, associationName=中国医师协会神经内科医师分会帕金森病及运动障碍学组, associationIntro=中国医师协会神经内科医师分会帕金森病及运动障碍学组, copyright=0, guiderPublishedTime=Wed Sep 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">帕金森病(Parkinson disease, PD)是一种常见的中枢神经系统变性疾病,随着疾病进展至中晚期后,PD并发症的出现使其治疗变得非常困难。近年来国际上对于中晚期PD的治疗和管理有了更多新的循证医学证据。中华医学会神经病学分会帕金森病及运动障碍学组和中国医师协会神经内科医师分会帕金森病及运动障碍学组组织有关专家,在循证医学原则指导下,就国内针对中晚期PD运动症状的现有干预措施研究进行总结,经多次讨论形成此指南,并就中晚期PD运动症状不同治疗措施的证据等级、推荐强度、安全性给出推荐,以更好地指导我国中晚期PD治疗的临床实践。&nbsp;</span></p>, tagList=[TagDto(tagId=337, tagName=帕金森病), TagDto(tagId=5308, tagName=神经变性疾病), TagDto(tagId=6032, tagName=运动症状)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5364, appHits=211, showAppHits=0, pcHits=341, showPcHits=5153, likes=3, shares=31, comments=5, approvalStatus=1, publishedTime=Fri Feb 11 15:17:00 CST 2022, publishedTimeString=2021-09-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 09 22:23:38 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 10:46:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国中晚期帕金森病运动症状治疗的循证医学指南.pdf)])
中国中晚期帕金森病运动症状治疗的循证医学指南.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2105678, encodeId=5a1e21056e8f7, content=为啥没反应, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58f76513948, createdName=ms4000001752382766, createdTime=Mon Dec 12 10:46:41 CST 2022, time=2022-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220398, encodeId=dcc51220398f9, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:38:59 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218042, encodeId=02e512180424f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon May 09 10:31:58 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205130, encodeId=c00b1205130d3, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6e5437912, createdName=ningjinyao, createdTime=Wed Mar 23 08:32:05 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204480, encodeId=0aec1204480e0, content=很接地气！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sun Mar 20 23:00:13 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-12-12 ms4000001752382766 来自陕西省

    为啥没反应

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2105678, encodeId=5a1e21056e8f7, content=为啥没反应, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58f76513948, createdName=ms4000001752382766, createdTime=Mon Dec 12 10:46:41 CST 2022, time=2022-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220398, encodeId=dcc51220398f9, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:38:59 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218042, encodeId=02e512180424f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon May 09 10:31:58 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205130, encodeId=c00b1205130d3, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6e5437912, createdName=ningjinyao, createdTime=Wed Mar 23 08:32:05 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204480, encodeId=0aec1204480e0, content=很接地气！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sun Mar 20 23:00:13 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-05-17 赛华佗

    #帕金森病#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2105678, encodeId=5a1e21056e8f7, content=为啥没反应, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58f76513948, createdName=ms4000001752382766, createdTime=Mon Dec 12 10:46:41 CST 2022, time=2022-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220398, encodeId=dcc51220398f9, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:38:59 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218042, encodeId=02e512180424f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon May 09 10:31:58 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205130, encodeId=c00b1205130d3, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6e5437912, createdName=ningjinyao, createdTime=Wed Mar 23 08:32:05 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204480, encodeId=0aec1204480e0, content=很接地气！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sun Mar 20 23:00:13 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-05-09 shirly.li19560809

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2105678, encodeId=5a1e21056e8f7, content=为啥没反应, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58f76513948, createdName=ms4000001752382766, createdTime=Mon Dec 12 10:46:41 CST 2022, time=2022-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220398, encodeId=dcc51220398f9, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:38:59 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218042, encodeId=02e512180424f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon May 09 10:31:58 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205130, encodeId=c00b1205130d3, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6e5437912, createdName=ningjinyao, createdTime=Wed Mar 23 08:32:05 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204480, encodeId=0aec1204480e0, content=很接地气！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sun Mar 20 23:00:13 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-23 ningjinyao

    学到了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2105678, encodeId=5a1e21056e8f7, content=为啥没反应, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58f76513948, createdName=ms4000001752382766, createdTime=Mon Dec 12 10:46:41 CST 2022, time=2022-12-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1220398, encodeId=dcc51220398f9, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:38:59 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218042, encodeId=02e512180424f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon May 09 10:31:58 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205130, encodeId=c00b1205130d3, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6e5437912, createdName=ningjinyao, createdTime=Wed Mar 23 08:32:05 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204480, encodeId=0aec1204480e0, content=很接地气！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Sun Mar 20 23:00:13 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-20 ms7000001100972409

    很接地气！

    0

相关指南

中国帕金森病重复经颅磁刺激治疗指南

中国医师协会神经内科医师分会 · 2021-12-22

帕金森病运动处方专家共识

上海中西医结合学会慢性神经系统疾病专业委员会 · 2021-12-16

帕金森病(颤拘病)中医临床诊疗专家共识

广州中医药大学第二附属医院 · 2021-11-26

中西医结合治疗早期帕金森病专家共识(2021)

上海市中医药学会神经科分会 · 2021-11-02

2021 AAN实践指南：早期帕金森病运动症状的多巴胺能疗法

美国神经病学学会(AAN,American Academy of Neurology) · 2021-11-16

帕金森病冻结步态中西医诊治专家共识（2021）

中国神经内科相关专家小组（统称） · 2021-10-20